ArticleFrontiers in oncology2026

BRAF V600E-mutated metastatic Wilms tumor with complete response to targeted RAF/MEK inhibition: a post-treatment follow-up case report.

Iliani Slika et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.